KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Chemed (CHE) over the last 17 years, with Q3 2025 value amounting to $17.4 million.

  • Chemed's Capital Expenditures rose 2815.8% to $17.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $59.2 million, marking a year-over-year increase of 2195.51%. This contributed to the annual value of $49.5 million for FY2024, which is 1288.04% down from last year.
  • According to the latest figures from Q3 2025, Chemed's Capital Expenditures is $17.4 million, which was up 2815.8% from $15.8 million recorded in Q2 2025.
  • In the past 5 years, Chemed's Capital Expenditures registered a high of $18.3 million during Q4 2022, and its lowest value of $10.9 million during Q3 2021.
  • Over the past 5 years, Chemed's median Capital Expenditures value was $13.5 million (recorded in 2022), while the average stood at $14.1 million.
  • As far as peak fluctuations go, Chemed's Capital Expenditures tumbled by 3548.93% in 2023, and later skyrocketed by 4290.36% in 2025.
  • Over the past 5 years, Chemed's Capital Expenditures (Quarter) stood at $14.2 million in 2021, then grew by 28.56% to $18.3 million in 2022, then crashed by 35.49% to $11.8 million in 2023, then rose by 8.34% to $12.8 million in 2024, then skyrocketed by 36.03% to $17.4 million in 2025.
  • Its last three reported values are $17.4 million in Q3 2025, $15.8 million for Q2 2025, and $13.3 million during Q1 2025.